© 2000 by European Society of Cardiology
Copyright © 2000, European Society of Cardiology
Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition
aAzerbaijan Medical University, Bakykhanov Str., Baku, Azerbaijan
bBristol Heart Institute, University of Bristol, Bristol Royal Infirmary, Bristol, UK
cDepartment of Pharmacology and Therapeutics, University of Calgary, Calgary, Alberta, Canada
dDepartment of Biochemistry, School of Medical Sciences, University of Bristol, University Walk, Bristol BS8 1TD, UK
* Corresponding author. Tel.: +44-117-928-8592; fax: +44-117-928-8274 a.halestrap{at}bristol.ac.uk
Objective: Diminishing oxidative stress may protect the heart against ischaemia–reperfusion injury by preventing opening of the mitochondrial permeability transition (MPT) pore. The general anaesthetic agent propofol, a free radical scavenger, has been investigated for its effect on the MPT and its cardioprotective action following global and cardioplegic ischaemic arrest. Method: Isolated perfused Wistar rat hearts were subjected to either warm global ischaemia (Langendorff) or cold St. Thomas’ cardioplegia (working heart mode) in the presence or absence of propofol. MPT pore opening was determined using [3H]-2-deoxyglucose-6-phosphate ([3H]-DOG-6P) entrapment. The respiratory function of isolated mitochondria was also determined for evidence of oxidative stress. Results: Propofol (2 µg/ml) significantly improved the functional recovery of Langendorff hearts on reperfusion (left ventricular developed pressure from 28.4±6.2 to 53.3±7.3 mmHg and left ventricular end diastolic pressure from 52.9±4.3 to 37.5±3.9 mmHg). Recovery was also improved in propofol (4 µg/ml) treated working hearts following cold cardioplegic arrest. External cardiac work on reperfusion improved from 0.42±0.05 to 0.60±0.03 J/s, representing 45–64% of baseline values, when compared to controls (P<0.05). Propofol inhibited MPT pore opening during reperfusion, [3H]-DOG-6P entrapment being 16.7 vs. 22.5 ratio units in controls (P<0.05). Mitochondria isolated from non-ischaemic, propofol-treated hearts exhibited increased respiratory chain activity and were less sensitive to calcium-induced MPT pore opening. Conclusion: Propofol confers significant protection against global normothermic ischaemia and during cold cardioplegic arrest. This effect is associated with less opening of mitochondrial MPT pores, probably as a result of diminished oxidative stress. Propofol may be a useful adjunct to cardioplegic solutions in heart surgery.
KEYWORDS AF, aortic flow-rate; AP, peak aortic pressure; CF, coronary flow-rate; CO, cardiac output; DOG, 2-deoxyglucose; DOG-6P, 2-deoxyglucose-6-phosphate; ECW, external cardiac work; EGTA, ethylene glycol-bis-(2-aminoethyl)-N,N,N',N'-tetraacetic acid; HR, heart rate; KHS, Krebs–Henseleit solution; LAP, left ‘atrial’ pressure; LVDP, left ventricular developed pressure; LVEDP, left ventricular end diastolic pressure; MPT, mitochondrial permeability transition; NTA, nitrilotriacetic acid; TMPD, N,N,N',N'-tetramethyl-p-phenylendiamine; RPP, rate-pressure product
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. T. Andrews, A. G. Royse, and C. F. Royse Functional comparison of anaesthetic agents during myocardial ischaemia-reperfusion using pressure-volume loops Br. J. Anaesth., November 1, 2009; 103(5): 654 - 664. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Javadov, M. Karmazyn, and N. Escobales Mitochondrial Permeability Transition Pore Opening as a Promising Therapeutic Target in Cardiac Diseases J. Pharmacol. Exp. Ther., September 1, 2009; 330(3): 670 - 678. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Ananthakrishnan, M. Kaneko, Y. C. Hwang, N. Quadri, T. Gomez, Q. Li, C. Caspersen, and R. Ramasamy Aldose reductase mediates myocardial ischemia-reperfusion injury in part by opening mitochondrial permeability transition pore Am J Physiol Heart Circ Physiol, February 1, 2009; 296(2): H333 - H341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. M. Hadzimichalis, S. S. Baliga, R. Golfetti, K. M. Jaques, B. L. Firestein, and G. F. Merrill Acetaminophen-mediated cardioprotection via inhibition of the mitochondrial permeability transition pore-induced apoptotic pathway Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3348 - H3355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Townsend, S. M. Davidson, S. J. Clarke, I. Khaliulin, C. J. Carroll, T. M. Scarabelli, R. A. Knight, A. Stephanou, D. S. Latchman, and A. P. Halestrap Urocortin prevents mitochondrial permeability transition in response to reperfusion injury indirectly by reducing oxidative stress Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H928 - H938. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Pieroni, A. Corti, B. Tota, F. Curnis, T. Angelone, B. Colombo, M. C. Cerra, F. Bellocci, F. Crea, and A. Maseri Myocardial production of chromogranin A in human heart: a new regulatory peptide of cardiac function Eur. Heart J., May 1, 2007; 28(9): 1117 - 1127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Roy, I. Friehs, D. B. Cowan, D. Zurakowski, F. X. McGowan, and P. J. del Nido Dopamine Induces Postischemic Cardiomyocyte Apoptosis In Vivo: An Effect Ameliorated by Propofol Ann. Thorac. Surg., December 1, 2006; 82(6): 2192 - 2199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Angelone, Y. Goumon, M. C. Cerra, M.-H. Metz-Boutigue, D. Aunis, and B. Tota The Emerging Cardioinhibitory Role of the Hippocampal Cholinergic Neurostimulating Peptide J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 336 - 344. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Marcil, K. Bourduas, A. Ascah, and Y. Burelle Exercise training induces respiratory substrate-specific decrease in Ca2+-induced permeability transition pore opening in heart mitochondria Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1549 - H1557. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Bovill Intravenous Anesthesia for the Patient with Left Ventricular Dysfunction Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2006; 10(1): 43 - 48. [Abstract] [PDF]
|
|
|
|
 |
|
 K. H. H. Lim, A. P. Halestrap, G. D. Angelini, and M.-S. Suleiman Propofol Is Cardioprotective in a Clinically Relevant Model of Normothermic Blood Cardioplegic Arrest and Cardiopulmonary Bypass Experimental Biology and Medicine, June 1, 2005; 230(6): 413 - 420. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ruiz-Meana, P. Pina, D. Garcia-Dorado, A. Rodriguez-Sinovas, I. Barba, E. Miro-Casas, M. Mirabet, and J. Soler-Soler Glycine protects cardiomyocytes against lethal reoxygenation injury by inhibiting mitochondrial permeability transition J. Physiol., August 1, 2004; 558(3): 873 - 882. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. King, H. Lin, J. D. McGivan, and M.-S. Suleiman Aspartate transporter expression and activity in hypertrophic rat heart and ischaemia-reperfusion injury J. Physiol., May 1, 2004; 556(3): 849 - 858. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Anselmi, A. Abbate, F. Girola, G. Nasso, G. G.L. Biondi-Zoccai, G. Possati, and M. Gaudino Myocardial ischemia, stunning, inflammation, and apoptosis during cardiac surgery: a review of evidence Eur. J. Cardiothorac. Surg., March 1, 2004; 25(3): 304 - 311. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P Halestrap, S. J Clarke, and S. A Javadov Mitochondrial permeability transition pore opening during myocardial reperfusion--a target for cardioprotection Cardiovasc Res, February 15, 2004; 61(3): 372 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. YELLON and J. M. DOWNEY Preconditioning the Myocardium: From Cellular Physiology to Clinical Cardiology Physiol Rev, October 1, 2003; 83(4): 1113 - 1151. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Shimono, T. Goromaru, Y. Kadota, T. Tsurumaru, and Y. Kanmura Propofol Displays No Protective Effect Against Hypoxia/Reoxygenation Injury in Rat Liver Slices Anesth. Analg., August 1, 2003; 97(2): 442 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Xia, D. V. Godin, and D. M. Ansley Propofol enhances ischemic tolerance of middle-aged rat hearts: effects on 15-F2t-isoprostane formation and tissue antioxidant capacity Cardiovasc Res, July 1, 2003; 59(1): 113 - 121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. H H Lim, S. A Javadov, M. Das, S. J Clarke, M-S. Suleiman, and A. P Halestrap The effects of ischaemic preconditioning, diazoxide and 5-hydroxydecanoate on rat heart mitochondrial volume and respiration J. Physiol., December 15, 2002; 545(3): 961 - 974. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Halmosi, Z. Berente, E. Osz, K. Toth, P. Literati-Nagy, and B. Sumegi Effect of Poly(ADP-Ribose) Polymerase Inhibitors on the Ischemia-Reperfusion-Induced Oxidative Cell Damage and Mitochondrial Metabolism in Langendorff Heart Perfusion System Mol. Pharmacol., June 1, 2001; 59(6): 1497 - 1505. [Abstract] [Full Text]
|
|